[Angina-like chest pain of esophageal origin]. 1989

M Bory, and B Dupin
Service de Cardiologie, Hôpital de la Timone, Marseille.

Chest pain of oesophageal origin closely resembles chest pain of coronary origin, and the distinction between these two sources of pain is crucial to give the patients a precise prognosis and to use the appropriate therapeutic approach. Once the coronary origin has formally been excluded, the oesophageal origin can be confirmed by several examinations of varying sensitivity and specificity. To date, prolonged oesophageal manometric and pH recordings give highly reliable results as they establish a cause-effect relationship between pain and the phenomena recorded. Besides, these methods have refined the therapeutic approach since they also inform on the mechanisms of oesophageal pain.

UI MeSH Term Description Entries
D008365 Manometry Measurement of the pressure or tension of liquids or gases with a manometer. Tonometry,Manometries
D008755 Methylergonovine A homolog of ERGONOVINE containing one more CH2 group. (Merck Index, 11th ed) Methylergobasin,Methylergometrin,Methergin,Methergine,Methylergometrine,Methylergometrine Maleate,Methylergonovine Maleate,Méthergin
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D002637 Chest Pain Pressure, burning, or numbness in the chest. Precordial Catch,Precordial Catch Syndrome,Texidor's Twinge,Chest Pains,Pain, Chest,Pains, Chest,Syndrome, Precordial Catch,Texidor Twinge
D004935 Esophageal Diseases Pathological processes in the ESOPHAGUS. Disease, Esophageal,Diseases, Esophageal,Esophageal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006851 Hydrochloric Acid A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE. Hydrogen Chloride,Muriatic Acid,Acid, Hydrochloric,Acid, Muriatic,Chloride, Hydrogen

Related Publications

M Bory, and B Dupin
October 1987, Bailliere's clinical gastroenterology,
M Bory, and B Dupin
April 1992, Zhonghua xin xue guan bing za zhi,
M Bory, and B Dupin
February 1981, The American journal of gastroenterology,
M Bory, and B Dupin
April 1977, The American journal of digestive diseases,
M Bory, and B Dupin
March 1999, Gastroenterologie clinique et biologique,
M Bory, and B Dupin
January 1999, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
M Bory, and B Dupin
July 2000, Current opinion in gastroenterology,
M Bory, and B Dupin
July 2001, Current opinion in gastroenterology,
M Bory, and B Dupin
July 2002, Current opinion in gastroenterology,
M Bory, and B Dupin
July 1999, Current opinion in gastroenterology,
Copied contents to your clipboard!